|
The ongoing Russia-Ukraine war has affected life saving medicines manufacturing of Indian drug exporter Kusum Healthcare Pvt. Ltd., as a Russian drone bombed its vital manufacturing facility in Sumy, Ukraine. The hit caused death, injuries and sufferings to innocent human lives, said the company condemning the attack. This was another catastrophic blow to an enterprise already reeling from the horrific events of April 14, 2025, when a Russian drone deliberately blew up the company's Ukrainian warehouse, it averred. "Since then, Kusum, backed by its core manufacturing powerhouses in India (2 units in Bhiwadi, Rajasthan, and 1 unit in SEZ-Pithampur, Indore, Madhya Pradesh) has been left completely abandoned and diplomatically bewildered as to why its healthcare lifeline is being dragged into a brutal military slaughter," said the company in a press statement. With losses of over UAH 1 billion from the previous attack, and total current damage projected to breach the $50 million mark, said that company also condemning "the deafening silence from the Government of India". Despite repeated pleas through Indian pharmaceutical forums to intervene at the highest levels of international diplomacy to protect private, life-saving businesses from the impact of war, Central government has offered not a single word of regret or support so far, it alleged. The attack has claimed life of atleast one employee on site, with several others gravely injured, as per preliminary information. "The India business and management authorities at Kusum Healthcare Pvt. Ltd. are urgently reviewing the unfolding catastrophe as damages surpass $50 million," said the company. The Kusum Group, headquartered in Delhi, India, has its overseas operations anchored by both Kusum Healthcare Private Limited for India and export markets, and Kusum for Ukraine.
|